Literature DB >> 20665591

Neurogenic marker abnormalities in the hippocampus in dementia with Lewy bodies.

Mary Johnson1, Antigoni Ekonomou, Carl Hobbs, Clive G Ballard, Robert H Perry, Elaine K Perry.   

Abstract

Dementia with Lewy bodies (DLB) is associated with alpha synuclein pathology and slowly progressive dementia. Progenitor abnormalities have previously been reported in the subventricular zone (SVZ) adjacent to the lateral ventricle. To evaluate changes in neural stem cells and progenitors in the hippocampal neurogenic niche, immunohistochemistry (IHC) using the neural stem cell markers Musashi 1, nestin, proliferating cell nuclear antigen (PCNA), doublecortin, and glial fibrillary acidic protein (GFAP) were examined in age-matched control and DLB groups. Staining was quantified in the hippocampal SVZ, subgranular layer (SGL) and ependymal cell layer (EPL). There was a significant loss in DLB of Musashi 1 (P < 0.01) in all areas, an increase in PCNA in hippocampal SVZ (P = 0.01) and SGL (P = 0.05), and an increase in doublecortin in the hippocampal SVZ (P = 0.04) and EPL (P = 0.02). This is the first report of the changes in neurogenic markers in the hippocampal SVZ and EPL in DLB and may offer the potential for understanding disease pathology and in the devising of treatment.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20665591     DOI: 10.1002/hipo.20826

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  10 in total

1.  Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology.

Authors:  Elaine K Perry; Mary Johnson; Antigoni Ekonomou; Robert H Perry; Clive Ballard; Johannes Attems
Journal:  Neurobiol Dis       Date:  2012-04-05       Impact factor: 5.996

Review 2.  Synucleinopathies: common features and hippocampal manifestations.

Authors:  Weiwei Yang; Shun Yu
Journal:  Cell Mol Life Sci       Date:  2016-11-08       Impact factor: 9.261

3.  Evidences for Adult Hippocampal Neurogenesis in Humans.

Authors:  Elena P Moreno-Jiménez; Julia Terreros-Roncal; Miguel Flor-García; Alberto Rábano; María Llorens-Martín
Journal:  J Neurosci       Date:  2021-03-24       Impact factor: 6.167

4.  Synergistic and additive effects of enriched environment and lithium on the generation of new cells in adult mouse hippocampus.

Authors:  Evelin L Schaeffer; Fabiana G Cerulli; Hélio O X Souza; Sergio Catanozi; Wagner F Gattaz
Journal:  J Neural Transm (Vienna)       Date:  2014-02-20       Impact factor: 3.575

5.  Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease.

Authors:  Zacharias Kohl; Nada Ben Abdallah; Jonathan Vogelgsang; Lucas Tischer; Janina Deusser; Davide Amato; Scott Anderson; Christian P Müller; Olaf Riess; Eliezer Masliah; Silke Nuber; Jürgen Winkler
Journal:  Neurobiol Dis       Date:  2015-10-30       Impact factor: 5.996

6.  Role of α-synuclein in adult neurogenesis and neuronal maturation in the dentate gyrus.

Authors:  Beate Winner; Martin Regensburger; Sebastian Schreglmann; Leah Boyer; Iryna Prots; Edward Rockenstein; Michael Mante; Chunmei Zhao; Jürgen Winkler; Eliezer Masliah; Fred H Gage
Journal:  J Neurosci       Date:  2012-11-21       Impact factor: 6.167

7.  Use of Ceftriaxone in Treating Cognitive and Neuronal Deficits Associated With Dementia With Lewy Bodies.

Authors:  Ying-Jui Ho; Mei-Shiuan Shen; Chun-Hwei Tai; Hsin-Hua Li; Jian-Horng Chen; Wen-Chieh Liao; Pai-Yi Chiu; I-Yen Lee; Chih-Li Lin; Ching-Sui Hung
Journal:  Front Neurosci       Date:  2019-05-24       Impact factor: 4.677

8.  Proliferation in the Alzheimer hippocampus is due to microglia, not astroglia, and occurs at sites of amyloid deposition.

Authors:  Michael W Marlatt; Jan Bauer; Eleonora Aronica; Elise S van Haastert; Jeroen J M Hoozemans; Marian Joels; Paul J Lucassen
Journal:  Neural Plast       Date:  2014-08-19       Impact factor: 3.599

9.  Allosteric inhibition of a stem cell RNA-binding protein by an intermediary metabolite.

Authors:  Carina C Clingman; Laura M Deveau; Samantha A Hay; Ryan M Genga; Shivender M D Shandilya; Francesca Massi; Sean P Ryder
Journal:  Elife       Date:  2014-06-16       Impact factor: 8.140

10.  Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson's Disease.

Authors:  Edward Rockenstein; Paula Desplats; Kiren Ubhi; Michael Mante; Jazmin Florio; Anthony Adame; Stefan Winter; Hemma Brandstaetter; Dieter Meier; Herbert Moessler; Eliezer Masliah
Journal:  J Exp Neurosci       Date:  2016-07-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.